Abeta amyloid deposition in the language system and how the brain responds.
Post-mortem measures of Abeta amyloid deposition correlate only weakly with cognitive dysfunction antemortem. We tested the hypothesis that functional reorganization forms a critical intermediary step between Abeta amyloid-associated brain injury and clinical disease expression. Fifteen patients with early-stage probable Alzheimer's disease (AD) and 16 cognitively intact controls participated in this combined functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) study. The fMRI design had two factors: task (associative-semantic versus visuoperceptual judgement) and input-modality (written words versus pictures). We measured Abeta amyloid by means of Pittsburgh Compound B (11C-PIB). In the posterior third of the left superior temporal sulcus (STS), the fMRI response during the associative-semantic compared with the visuoperceptual task was lower in AD than in controls, in particular for words. Response amplitude correlated inversely with PIB uptake in this region. Contralaterally, the functional pattern differed substantially: the fMRI response in the right posterior STS during the associative-semantic versus the visuoperceptual task was higher in AD than in controls. Accuracy on the Boston Naming test correlated positively with the degree to which AD patients were able to recruit the right STS (r = 0.84, P(corrected) = 0.014). PIB uptake did not correlate with naming accuracy. Functional reorganization of the language system in response to Abeta amyloid-related brain injury exists in early-stage AD and determines the degree of anomia more than Abeta amyloid load per se does.
Nelissen
Natalie
N
Cognitive Neurology Laboratory, KU Leuven, Belgium.
Vandenbulcke
Mathieu
M
Fannes
Katrien
K
Verbruggen
Alfons
A
Peeters
Ronald
R
Dupont
Patrick
P
Van Laere
Koen
K
Bormans
Guy
G
Vandenberghe
Rik
R
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology / Q000523:psychology; D016229:Amyloid beta-Peptides / Q000032:analysis*; D000849:Anomia / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D001921:Brain / Q000503:physiopathology; D001931:Brain Mapping / Q000379:methods; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000379:methods; D007806:Language Disorders / Q000209:etiology* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008297:Male; D009483:Neuropsychological Tests; D049268:Positron-Emission Tomography; D012660:Semantics; D013702:Temporal Lobe / Q000737:chemistry / Q000473:pathology
D016229:Amyloid beta-Peptides